Shennon Biotechnologies is a pioneering biotech company based in San Francisco, specializing in single cell functional profiling to advance immunotherapy. Utilizing their proprietary platform, they achieve unprecedented throughput and accuracy in analyzing immune cells, which aids in discovering new immunotherapy targets and developing curative treatments for solid tumors and autoimmune diseases. Funded by leading investors including DCVC, Foundation Capital, and AV8, ShennonBio is at the forefront of transforming cancer treatment through cutting-edge technology.
Open Positions
Join our Talent Pool!
Strong commitment to collaboration, ownership, and authenticity, and demonstrated experience in your field of expertise
Scientist / Senior Scientist - TCR engineering and TCE development
PhD in Biochemistry, Molecular Biology, Bioengineering, Immunology, or a related field, and expertise in yeast display technologies, and high-throughput TCR/antibody screening
CSO / VP of R&D
Ph.D. in immuno-oncology, 10+ years of R&D experience, domain expertise in immuno-oncology and soluble TCRs, and ability to lead and scale a pre-clinical company